BioArctic’s global license agreement with Bristol Myers Squibb for PyroGlu-Aß antibody programme effective after antitrust clearance and closing: Stockholm, Sweden Saturday, Fe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback